Showing results (31-40 of 61) with videos related to

Sort By:
Pageof 7
Gastroenterologia Y Hepatologia|July 18, 2025
Predictors of early immunosuppression at ulcerative colitis onset in the biological eraGisela Piñero, Edgar Castillo, Carlos González-Muñoza, et al.
Journal of Crohn'S & Colitis|July 29, 2014
Intravenous corticosteroids in moderately active ulcerative colitis refractory to oral corticosteroidsJordina Llaó, Juan E Naves, Alexandra Ruiz-Cerulla, et al.
United European Gastroenterology Journal|March 8, 2018
Prevalence and risk factors for colorectal adenomas in patients with ulcerative colitisJordi Gordillo, Yamile Zabana, Esther Garcia-Planella, et al.
Gastroenterologia Y Hepatologia|May 9, 2024
Perception of the impact of intravenous biological treatment on the work and professional environment in patients with inflammatory bowel diseaseCarlos González-Muñoza, Cristina Gely, Jordi Gordillo, et al.
Gastroenterologia Y Hepatologia|November 28, 2015
[Chronic diarrhoea: Definition, classification and diagnosis]Fernando Fernández-Bañares, Anna Accarino, Agustín Balboa, et al.
Plos One|April 11, 2014
Interleukin-19 impairment in active Crohn's disease patientsElisabet Cantó, Esther Garcia Planella, Carlos Zamora-Atenza, et al.
Gastroenterologia Y Hepatologia|September 30, 2022
Clinical and endoscopic outcomes of patients with colonic Crohn's disease treated with 5-aminosalicylates as monotherapyEdgar Castillo-Regalado, Raquel Ríos, Clàudia Aràjol, et al.
Aging Clinical and Experimental Research|June 24, 2021
Impact of immunosuppressants on SARS-CoV-2 infection in elderly patients with inflammatory bowel diseaseMargalida Calafat, Carlos González-Muñoza, Marta Fortuny, et al.
Journal of Crohn'S & Colitis|October 23, 2018
Prognostic Value of the Burden of Cytomegalovirus Colonic Reactivation Evaluated by Immunohistochemical Staining in Patients with Active Ulcerative ColitisAriadna Clos-Parals, Paula Rodríguez-Martínez, Fiorella Cañete, et al.
Pageof 7